BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
113.08
+1.74 (1.56%)
Dec 20, 2024, 4:00 PM EST - Market closed
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $27.11 billion as of December 20, 2024. Its market cap has increased by 11.89% in one year.
Market Cap
27.11B
Enterprise Value
8.75B
1-Year Change
11.89%
Ranking
Category
Stock Price
$113.08
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $27.11B, an increase of 805.17%. That is a compound annual growth rate of 52.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 27.11B | 8.06% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | 19.63B | 156.06% |
| Dec 31, 2019 | 7.67B | 155.95% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alnylam Pharmaceuticals | 30.81B |
| Centene | 30.15B |
| DexCom | 29.61B |
| Humana | 28.39B |
| Cardinal Health | 28.32B |
| Mettler-Toledo International | 25.45B |
| Teva Pharmaceutical | 24.18B |
| West Pharmaceutical Services | 23.68B |